URSA-QUALITY-SPC1: Statin Therapy for ASCVD Patients (SPC1)
- 17 Dec 2024
- 1 Minute to read
- Print
- DarkLight
URSA-QUALITY-SPC1: Statin Therapy for ASCVD Patients (SPC1)
- Updated on 17 Dec 2024
- 1 Minute to read
- Print
- DarkLight
Article summary
Did you find this summary helpful?
Thank you for your feedback
Measure Description
Among patients with atherosclerotic cardiovascular disease, the percentage with any dispensed moderate- or high-intensity statin in the prior 12 months. Unadjusted Certified Measure c22c23d3-e057-4e7a-8685-e21ad66d8112
Metadata
- Measure Type: Rate Measure
- Temporal Structure: Entity
- Component Class: Long-Form
- Denominator Case Field: Patient ID, Output NCQA Payer Type Code
- Target Direction: Up
Denominator Description
Patients with atherosclerotic cardiovascular disease.
Numerator Description
One per qualifying denominator patient with documentation of a moderate- or high-intensity statin dispensed in the prior 12 months.
*HEDISĀ® is a registered trademark of the National Committee for Quality Assurance
Was this article helpful?